Endocyte's Chief Commercial Officer just cashed-in 10,000 options

David D. Meek, Endocyte's Chief Commercial Officer, recently cashed-in 10,000 options. The options were exercised at $8.73, while the sales took place at $15.50 per share, on September 12, 2013. Meek no longer owns any shares of the company. Meek operates out of West Lafayette, IN. Some additional info was provided as follows:

Shares subject to the option vest 1/4 annually over a four (4) year period beginning on August 3, 2013.

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever Endocyte makes a similar move, sign up!

   Auto Refresh